Maynard Um
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
-
-
-
-
-
-
-
BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
-
-
-
-
-
-
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $485 at H.C. Wainwright
-
-
-
-
-
-
-
GENESIS Pharma expands Alnylam partnership to Nordic markets
-
-
-
-
-
-
-
U.S. Biotech stocks: Q1 earnings previews
-
-
-
-
-
-
-
Alnylam partners with Viz.ai and American Heart Association on ATTR-CM care
-
-
-
-
-
-
-
Alnylam Pharma (ALNY) Tops Q4 EPS by 6c, Misses on Revenue; Offers FY26 Revenue Guidance
-
459,888 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


